Pure Global AI
Registration holder profile

GRIFOLS BRASIL LTDA

Brazil147 ANVISA registrations40 unique technical categoriesOct 23, 2001 – Aug 10, 2026
Verified
147
Total products
40
Technical names
Oct 2001
Earliest registration
Aug 2026
Latest registration
Regulatory footprint
Search GRIFOLS BRASIL LTDA across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this holder
IMMUNOHEMATOLOGY - RARE SERA FOR COLUMN TECHNOLOGY
Anti-H for DG Gel
Class III · Aug 10, 2026
PLASMODIUM
Procleix Plasmodium Assay Calibrators
Class IV · Mar 16, 2026
FLASK OR MATERIAL FOR COLLECTION, STORAGE OR TRANSPORT OF BIOLOGICAL SAMPLES
ORAcollect DNA
Class I · Jan 12, 2026
HIV, HBV AND HCV VIRUS NUCLEIC ACID
Discriminatory Probe Reagent kit (Procleix UltrioPlex E)
Class IV · Sep 15, 2025
HIV, HBV AND HCV VIRUS NUCLEIC ACID
Target Enhancer Reagent Kit - Procleix Ultrio Elite Assay
Class IV · Jul 28, 2025
Most popular products
Products with most registrations
IMMUNOHEMATOLOGY - ABO - HUMAN ORIGIN
17 registrations
IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
14 registrations
TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
12 registrations
IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY
10 registrations
IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS
10 registrations
Top manufacturers
Manufacturers with the most products registered by this holder
MEDION GRIFOLS DIAGNOSTICS AG
41 products
DIAGNOSTIC GRIFOLS, S.A.
35 products
GRIFOLS DIAGNOSTICS SOLUTIONS INC
21 products
PROGENIKA BIOPHARMA S.L.
10 products
DELCON S.R.L.
8 products
Products per risk level
Distribution of distinct commercial products by ANVISA risk classification
Class I34Distinct Products · 34 total registrations
Class II25Distinct Products · 25 total registrations
Class III32Distinct Products · 32 total registrations
Class IV56Distinct Products · 56 total registrations
About this profile

Access comprehensive registration holder profile for GRIFOLS BRASIL LTDA through Pure Global AI's free Brazil medical device database. This registration holder manages 147 medical device registrations with ANVISA across 40 unique technical categories. Their regulatory portfolio spans from Oct 23, 2001 to Aug 10, 2026.

This page provides comprehensive insights including 5 recent product registrations with the latest being IMMUNOHEMATOLOGY - RARE SERA FOR COLUMN TECHNOLOGY (Anti-H for DG Gel), 5 most popular products led by IMMUNOHEMATOLOGY - ABO - HUMAN ORIGIN with 17 registrations, partnerships with 5 key manufacturers including MEDION GRIFOLS DIAGNOSTICS AG and DIAGNOSTIC GRIFOLS, S.A., and products across 4 risk classifications with 34 Class I devices. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping distributors understand market dynamics and identify business opportunities.